Related Experiment Video

Updated: Jun 3, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Intratumor RNA interference of cell cycle genes slows down tumor progression

S Dharmapuri1, D Peruzzi, E Marra

  • 1Merck Research Laboratories, IRBM P Angeletti, Pomezia (Rome), Italy.

Gene Therapy
|March 11, 2011
PubMed

Insights

Lipid-based nanoparticles (LNPs) and adenoviruses (Ads) effectively deliver small interfering RNAs (siRNAs) to tumors, silencing target genes and slowing cancer progression. This research advances targeted cancer gene silencing strategies.

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Oncology

Background:

  • Small interfering RNAs (siRNAs) show therapeutic potential for gene expression modulation.
  • Bioavailability and targeted delivery challenges hinder clinical siRNA application.
  • Lipid-based nanoparticles (LNPs) and viral vectors (adenoviruses, Ads) are promising delivery systems.

Purpose of the Study:

  • To evaluate the efficacy of LNPs and Ads in delivering siRNAs for in vivo tumor transduction and treatment.
  • To assess the gene silencing capabilities of these delivery systems against reporter and therapeutic target genes.
  • To determine the impact of gene silencing on tumor progression and cell cycle.

Main Methods:

  • In vivo testing of LNPs and Ads for tumor transduction.
  • siRNA delivery to silence luciferase, kinesin spindle protein (KIF11), and polo-like kinase 1.
  • Assessment of gene knockdown, cell cycle effects, and tumor growth inhibition.

Main Results:

  • Efficient gene knockdown of reporter and therapeutic targets (KIF11, polo-like kinase 1) was achieved in tumors.
  • Observed cell cycle arrest in tumor cells.
  • Significant slowing of tumor progression in treated animals.

Conclusions:

  • LNPs and Ads can effectively transduce tumors with siRNAs in vivo.
  • Gene silencing via these vectors leads to therapeutic effects, including slowed tumor progression.
  • Further development of non-viral particles for targeted cancer gene silencing is warranted.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...